HomeOpen Access NewsSH Translational Imaging Innovations

SH Translational Imaging Innovations

Degenerative eye disease and the opportunities of ophthalmic drug development

Eric Buckland of Translational Imaging Innovations looks at ophthalmic drug development and how better clinical endpoints can improve success rates.

Clinical Endpoints and data management in the era of ophthalmic precision medicine

Eric Buckland of Translational Imaging Innovations and Ronald Schuchard, Clinical Product Development Expert, explore the benefits of ophthalmic precision medicine to improve patient care across sectors.

Data capture for researching degenerative eye disease

Translational Imaging Innovations makes data accessible to research degenerative eye disease.

The global cost of visual impairment

250 million people suffer from visual impairment at a global cost of $3 trillion, Translational Imaging Innovations explain.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders